Zai Lab Limited (ZLAB) Announces Proposed 5.5M ADS Common Offering

Go back to Zai Lab Limited (ZLAB) Announces Proposed 5.5M ADS Common Offering

Zai Lab Limited (ZLAB) Prcies 5.5M ADS Offering at $47.50/ADS

January 23, 2020 5:51 AM UTC

Zai Lab Limited (NASDAQ: ZLAB), a China and U.S.-based innovative commercial stage biopharmaceutical company, today announced the pricing of its underwritten public offering of 5,500,000 American depositary shares (ADSs), each representing one ordinary share of the Company (the Primary ADS Offering), at a price of US$47.50 per ADS. In addition, QM11 Limited, a shareholder of the... More